Kaplan-Meier graphs for breast cancer incidence in the tamoxifen

Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours

Ivana SESTAK, Associate Professor in Medical Statistics

2021 Update on Systemic Therapy for Breast Cancer Published in healthbook TIMES Oncology Hematology

A generalizable relationship between mortality and time-to-death among breast cancer patients can be explained by tumour dormancy

Femara: Package Insert / Prescribing Information

Kaplan Meier breast cancer survival curve for CYP2D6*4 genotype.

Ivana SESTAK, Associate Professor in Medical Statistics

JCM, Free Full-Text

Tamoxifen Use in Postmenopausal Breast Cancer: CYP2D6 Matters

Kaplan-Meier graphs for the disease-free and overall survival rates of

Comprehensive Analysis of RNA-Binding Protein-Related lncRNA in Breast Invasive Carcinoma

A. Kaplan–Meier analysis was used to evaluate overall s

Ivana SESTAK, Associate Professor in Medical Statistics

Kaplan–Meier analysis of DFS breast cancer patients. a DFS depends on

Tamoxifen therapy benefit for patients with 70-gene signature high and low risk